Azizi F, Vagenakis A G, Portnay G I, Rapoport B, Ingbar S H, Braverman L E
N Engl J Med. 1975 Feb 6;292(6):273-7. doi: 10.1056/NEJM197502062920601.
To develop a test of pituitary-thyroid responsiveness to thyrotropin-releasing hormone that would obviate the need for measuring serum thyrotropin, we determined serum thyrotropin, thyroxine, and tri-iodothyronine concentrations before and at frequent intervals after the intramuscular administration of 2 mg of thyrotropin-releasing hormone in normal subjects and in patients with a variety of thyroid disorders. In specimens obtained four and five hours after administration of the hormone to normal subjects, serum thyroxine concentration increased 2.4 plus or minus 0.7 mug per 100 ml (mean plus or minus S.D.) over base-line values, the magnitude of increase being greater than 1.5 mug per 100 ml in 32 of 34 subjects. Serum thyroxine concentrations after administration of thyrotropin-releasing hormone did not increase in 11 hyperthyroid patients. Of 13 with hypothyroidism, increases in 12 were 0 to 0.7 mug per 100 ml; in one the increment was 1.2 mug per 100 ml. Measurement of the serum thyroxine response to intramuscular thyrotropin-releasing hormone will usually suffice to determine the integrity of the hypothalamic-pituitary-thyroid complex.
为了开发一种垂体 - 甲状腺对促甲状腺激素释放激素反应性的检测方法,以避免测量血清促甲状腺激素的需求,我们在正常受试者和患有各种甲状腺疾病的患者中,于肌肉注射2mg促甲状腺激素释放激素之前及之后的频繁时间间隔测定血清促甲状腺激素、甲状腺素和三碘甲状腺原氨酸浓度。在向正常受试者注射激素后4小时和5小时采集的样本中,血清甲状腺素浓度比基线值每100ml增加2.4±0.7μg(平均值±标准差),34名受试者中有32名的增加幅度大于每100ml 1.5μg。11名甲状腺功能亢进患者在注射促甲状腺激素释放激素后血清甲状腺素浓度未增加。13名甲状腺功能减退患者中,12名的增加量为每100ml 0至0.7μg;1名的增量为每100ml 1.2μg。测量血清甲状腺素对肌肉注射促甲状腺激素释放激素的反应通常足以确定下丘脑 - 垂体 - 甲状腺复合体的完整性。